158 related articles for article (PubMed ID: 20108468)
1. Malignant insulinoma with hepatic and pulmonary metastases associated with primary hyperparathyroidism. Case report and review of the literature.
Albu A; Zirnea A; Georgescu O; Terzea D; Jinga D; Fica S
J Med Life; 2008; 1(2):210-7. PubMed ID: 20108468
[TBL] [Abstract][Full Text] [Related]
2. Malignant insulinoma presenting as metastatic liver tumor. Case report and review of the literature.
Baldelli R; Ettorre G; Vennarecci G; Pasimeni G; Carboni F; Lorusso R; Barnabei A; Appetecchia M
J Exp Clin Cancer Res; 2007 Dec; 26(4):603-7. PubMed ID: 18365560
[TBL] [Abstract][Full Text] [Related]
3. Prompt resolution of hypoglycemia by hepatic transarterial embolization for malignant insulinoma with multiple liver metastases.
Muro S; Nasu J; Harada R; Matsubara M; Nakarai A; Kanzaki H; Tsutsumi K; Kato H; Tanaka T; Fujiwara H; Uno M; Okada H; Yamamoto K
Acta Med Okayama; 2014; 68(5):303-6. PubMed ID: 25338488
[TBL] [Abstract][Full Text] [Related]
4. Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.
Romeo S; Milione M; Gatti A; Fallarino M; Corleto V; Morano S; Baroni MG
Horm Res; 2006; 65(3):120-5. PubMed ID: 16479142
[TBL] [Abstract][Full Text] [Related]
5. Insulinoma with focal hepatic lesions: malignant insulinoma?
Jerraya H; Zidi-Mouaffek Y; Dokmak S; Dziri C
BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26670896
[TBL] [Abstract][Full Text] [Related]
6. Malignant insulinoma: permanent hepatic artery embolization of liver metastases--preliminary results.
Winkelbauer FW; Nierderle B; Graf O; Prokesch R; Thurnher S; Wildling R; Lammer J
Cardiovasc Intervent Radiol; 1995; 18(6):353-9. PubMed ID: 8591620
[TBL] [Abstract][Full Text] [Related]
7. [Malignant insulinoma].
Tóth M; Szücs N; Jakab Z; Doros A; Nemes Z; Rácz K
Orv Hetil; 2011 Mar; 152(10):398-402. PubMed ID: 21354956
[TBL] [Abstract][Full Text] [Related]
8. Pasireotide for malignant insulinoma.
Tirosh A; Stemmer SM; Solomonov E; Elnekave E; Saeger W; Ravkin Y; Nir K; Talmor Y; Shimon I
Hormones (Athens); 2016 Apr; 15(2):271-276. PubMed ID: 26732164
[TBL] [Abstract][Full Text] [Related]
9. Rapidly progressing malignant insulinoma presented with multiple liver metastases: a case report.
Erdogan A; Kose F; Akkaya H; Bascil Tutuncu N; Ozyilkan O
J Gastrointest Cancer; 2010 Dec; 41(4):272-4. PubMed ID: 20419482
[TBL] [Abstract][Full Text] [Related]
10. Focal hepatic steatosis surrounding a metastatic insulinoma.
Takeshita A; Yamamoto K; Fujita A; Hanafusa T; Yasuda E; Shibayama Y
Pathol Int; 2008 Jan; 58(1):59-63. PubMed ID: 18067643
[TBL] [Abstract][Full Text] [Related]
11. Long delay in diagnosis of a case with MEN1 due to concomitant presence of AIMAH with insulinoma: a case report and literature review.
Chavoshi V; Tamehri Zadeh SS; Khalili S; Rabbani A; Matini SAH; Mohsenifar Z; Hadaegh F
BMC Endocr Disord; 2022 Apr; 22(1):108. PubMed ID: 35448982
[TBL] [Abstract][Full Text] [Related]
12. Radio-frequency ablation for symptom control in a patient with metastatic pancreatic insulinoma.
Scott A; Hinwood D; Donnelly R
Clin Endocrinol (Oxf); 2002 Apr; 56(4):557-9. PubMed ID: 11966750
[TBL] [Abstract][Full Text] [Related]
13. Metastatic insulinoma: case report and review of the literature.
Tran TH; Pathak RD; Basa AL
South Med J; 2004 Feb; 97(2):199-201. PubMed ID: 14982275
[TBL] [Abstract][Full Text] [Related]
14. Malignant metastatic insulinoma-postoperative treatment and follow-up.
Starke A; Saddig C; Mansfeld L; Koester R; Tschahargane C; Czygan P; Goretzki P
World J Surg; 2005 Jun; 29(6):789-93. PubMed ID: 15880279
[TBL] [Abstract][Full Text] [Related]
15. Insulinoma with subsequent association of Zollinger-Ellison syndrome.
Mizuno N; Naruse S; Kitagawa M; Ishiguro H; Ito O; Ko SB; Yoshikawa T; Tanahashi C; Ito M; Hayakawa T
Intern Med; 2001 May; 40(5):386-90. PubMed ID: 11393407
[TBL] [Abstract][Full Text] [Related]
16. Pasireotide for Refractory Hypoglycemia in Malignant Insulinoma- Case Report and Review of the Literature.
Oziel-Taieb S; Maniry-Quellier J; Chanez B; Poizat F; Ewald J; Niccoli P
Front Endocrinol (Lausanne); 2022; 13():860614. PubMed ID: 35518928
[TBL] [Abstract][Full Text] [Related]
17. Malignant insulinoma presenting with recurrent episodic loss of consciousness.
Misra UK; Pandey BN; Pradhan S; Bal S; Mithal A; Bhatia I
J Assoc Physicians India; 1991 Oct; 39(10):771-3. PubMed ID: 1816206
[TBL] [Abstract][Full Text] [Related]
18. Images of interest. Hepatobiliary and pancreatic: Insulinoma metastases with focal hepatic steatosis.
Sumiyoshi S; Kobayashi Y; Souda K; Takehara Y; Nakamura H
J Gastroenterol Hepatol; 2005 Apr; 20(4):650. PubMed ID: 15836720
[No Abstract] [Full Text] [Related]
19. Transformation of nonfunctioning pancreatic tumor into malignant insulinoma after 3 years: an uncommon clinical course of insulinoma.
Arslan MS; Ozbek M; Karakose M; Tutal E; Ucan B; Yilmazer D; Dilli A; Gultekin SS; Cakal E; Delibasi T
Arch Endocrinol Metab; 2015 Jun; 59(3):270-2. PubMed ID: 26154097
[TBL] [Abstract][Full Text] [Related]
20. A case of multiple endocrine neoplasia type 1 with primary liver gastrinoma.
Lee SR; Choi MC; Ahn KJ
J Korean Med Sci; 2010 Jun; 25(6):953-6. PubMed ID: 20514321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
